A clinical trial to study the effect of the drug Suringiyathi Chooranam for the management of patients with Sinusitis( Azhal thalainokkadu)

Phase II Non-randomized open clinical evaluation of siddha medicine Suringiyathi Chooranam for the management of Azhal Thalainokkadu (Sinusitis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037652

Enrollment

Registered

2021-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J019- Acute sinusitis, unspecified

Interventions

Intervention1: Suringiyathi Chooranam: 2gms of Suringiyathi Chooranam idhu administered twice a day with hot water for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Rhinorrhoea Headache Pain and tenderness over para nasal sinus Recurrent sneezing Hyposmia or anosmia Nasal congestion

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Vasomotor rhinitis Opthalmic headache Migraine Otitis media

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity scoreTimepoint: Primary outcome is mainly assessed by reduction of clinical symptoms after 48 days and also assessed by Adelaide symptoms severity score	—

Secondary

Measure	Time frame
Secondary outcome is mainly assessed by comparing the safety parameters before and after treatmentTimepoint: 48days	—

Countries

India

Contacts

Public ContactDr Chithra U

Government Siddha Medical College

mmsankar2000@gmail.com9025006404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026